Axing staff and shelving cancer programs, Selecta hopes laser focus on gout will prove a way out
As Werner Cautreels completes his retirement form Selecta Biosciences, new CEO Carsten Brunn is left on his own to start the year off with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.